Research has shown that siRNA silencing of PERK or ATF6 can inhibit viral replication in NDV-infected human non-small-cell lung cancer (NSCLC) cell line A549 and SVV-infected BHK-21 cells [140, 142]. This evidence concerns the gene EIF2AK3 and non-small cell lung carcinoma.